Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00623545 · ClinicalTrials.gov registry record · Phase 4
Bioenergetic Alterations After Exenatide Administration
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT00623545 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 28 participants.
The verdict
NCT00623545, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to find out how exenatide causes weight loss. Specifically, the study is assessing how exenatide may change how people take in energy (energy intake), as well as how it may effect how people use energy (energy expenditure).
Interventions
- DRUG Exenatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00623545
The ClinicalTrials.gov registry entry for NCT00623545 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exenatide is the first listed.
NCT00623545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00623545 about?
NCT00623545 is a clinical study titled "Bioenergetic Alterations After Exenatide Administration". The purpose of this study is to find out how exenatide causes weight loss. Specifically, the study is assessing how exenatide may change how people take in energy (energy intake), as well as how it may effect how people use energy (energy expenditure).
What is the current status of trial NCT00623545?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2008-01. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00623545?
The interventions under investigation include: Exenatide (DRUG).
Who is sponsoring clinical trial NCT00623545?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.